Cero Therapeutics Holdings, INC. (CEROW) — 10-Q Filings

All 10-Q filings from Cero Therapeutics Holdings, INC.. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.

10-Q Filings (6)

CERO Therapeutics Faces Delisting, Deepening Losses Amid Financing Rounds — Nov 19, 2025 Risk: high
CERO THERAPEUTICS HOLDINGS, INC. (CEROW) reported no revenue for the three and nine months ended September 30, 2025, consistent with its pre-commercial stage. T
CERO Therapeutics Posts $10.5M Q2 Loss Amid Financing & Stock Splits — Aug 22, 2025 Risk: high
CERO THERAPEUTICS HOLDINGS, INC. (CEROW) reported no revenue for the three and six months ended June 30, 2025, consistent with its pre-commercial stage. The com
Cero Therapeutics Files Q1 2025 10-Q Report — May 15, 2025 Risk: low
Cero Therapeutics Holdings, Inc. filed its quarterly report on Form 10-Q for the period ended March 31, 2025. The company, formerly known as Phoenix Biotech Acq
Cero Therapeutics Files Q3 2024 Report — Nov 19, 2024 Risk: low
Cero Therapeutics Holdings, Inc. filed its quarterly report for the period ending September 30, 2024. The company, formerly known as Phoenix Biotech Acquisition
Cero Therapeutics Holdings Files Q2 2024 10-Q — Aug 14, 2024 Risk: low
Cero Therapeutics Holdings, Inc. filed its quarterly report for the period ended June 30, 2024. The company, formerly known as Phoenix Biotech Acquisition Corp.
Cero Therapeutics Holdings Files Q1 2024 10-Q — May 17, 2024 Risk: low
Cero Therapeutics Holdings, Inc. filed its quarterly report for the period ending March 31, 2024. The company, formerly known as Phoenix Biotech Acquisition Cor

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX